Max Zhu, Ph.D.
Head of Computer Aided Drug Design
Dr. Zhu is responsible for leading computer aided-drug design and modeling activities. Dr. Zhu received a Ph.D. from the Department of Chemistry at the University of Cambridge in drug discovery research for Alzheimer’s disease (AD) in a highly multi-disciplinary research environment, benefited from his previous diverse trainings in computer science, biology, genetics and chemistry. Dr. Zhu has worked as a scientist entrepreneur in a number of biotech companies globally.
Balász Herberth, Ph.D.
Head of cell biology and in vitro pharmacology
Dr. Herberth is responsible for development and application of cell biology disease models applied in Cantabio’s therapeutic programs. Dr. Herberth previously was a senior scientist focusing on drug discovery research for CNS indications at the Laboratory of Molecular Pharmacology at EGIS Pharmaceuticals, wholly owned subsidiary of Servier Group between 2009 and 2015.